Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Nuomingkang Pharmaceutical Research Institute is a specialized pharmaceutical research and development organization based in Jinan, China. Founded in 2014, the institute focuses on the development of high-end generic drugs and innovative small molecule therapeutics. Its core competencies include chemical synthesis, complex formulation development, and comprehensive quality control research. The company provides a wide range of services to the pharmaceutical industry, including technology transfer, consistency evaluation, and regulatory registration support. Nuomingkang has established a robust technical platform that facilitates the transition of drug candidates from laboratory research to industrial-scale production. The institute is particularly recognized for its work in the cardiovascular, metabolic, and anti-infective therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Nuomingkang Pharmaceutical Research Institute.